DEUTSCHE BANK AG\ - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 131 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$102,000
-44.3%
38,145
-9.9%
0.00%
Q4 2021$183,000
-9.9%
42,323
+6.2%
0.00%
Q3 2021$203,000
-21.0%
39,849
-1.6%
0.00%
Q2 2021$257,000
-19.7%
40,510
-2.0%
0.00%
Q1 2021$320,000
-44.1%
41,353
-52.6%
0.00%
Q4 2020$572,000
-26.4%
87,329
-25.3%
0.00%
-100.0%
Q3 2020$777,000
+53.3%
116,894
+92.0%
0.00%
Q2 2020$507,000
+23.7%
60,886
+14.1%
0.00%
Q1 2020$410,000
-72.2%
53,382
-70.0%
0.00%
-100.0%
Q4 2019$1,476,000
+1.1%
177,799
-10.2%
0.00%0.0%
Q3 2019$1,460,000
-54.0%
197,898
-30.1%
0.00%
-50.0%
Q2 2019$3,176,000
+473.3%
283,310
+446.6%
0.00%
Q1 2019$554,000
+40.3%
51,831
+97.2%
0.00%
Q4 2018$395,000
-93.2%
26,280
-91.6%
0.00%
-100.0%
Q3 2018$5,773,000
+47.9%
312,119
+82.8%
0.00%
+100.0%
Q2 2018$3,903,000
+63.5%
170,783
+103.4%
0.00%0.0%
Q1 2018$2,387,000
+58.2%
83,984
+17.3%
0.00%0.0%
Q4 2017$1,509,000
-58.1%
71,569
-63.9%
0.00%
-50.0%
Q3 2017$3,602,000
+120.8%
198,331
+88.4%
0.00%
+100.0%
Q2 2017$1,631,000
+238.4%
105,283
+276.4%
0.00%
Q1 2017$482,000
+254.4%
27,968
+125.6%
0.00%
Q4 2016$136,000
+161.5%
12,396
+267.7%
0.00%
Q3 2016$52,000
+67.7%
3,371
+7.3%
0.00%
Q2 2016$31,000
+106.7%
3,142
+168.1%
0.00%
Q1 2016$15,000
-61.5%
1,172
-39.2%
0.00%
Q4 2015$39,0001,9280.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders